Givinostat hydrochloride monohydrate is the monohydrate form of givinostat hydrochloride. It is a histone deacetylase inhibitor indicated for the treatment of Duchenne muscular dystrophy in patients 6 years of age and older. Among its listed roles, it functions as a angiogenesis inhibitor, an anti-inflammatory agent, an antineoplastic agent, an apoptosis inducer and an EC 3.5.1.98 (histone deacetylase) inhibitor. It includes a givinostat hydrochloride. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Givinostat and Givinostat hydrochloride monohydrate. Its PubChem CID is 9804991.
Givinostat hydrochloride hydrate
| CAS No | 732302-99-7 |
|---|---|
| Molecular Formula | C24H30ClN3O5 |
| Molecular Weight | 476.0 g/mol |
| Synonyms | [6-(diethylaminomethyl)naphthalen-2-yl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate;hydrate;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Givinostat hydrochloride monohydrate is the monohydrate form of givinostat hydrochloride. It is a histone deacetylase inhibitor indicated for the treatment of Duchenne muscular dystrophy in patients 6 years of age and older.
The listed CAS number is 732302-99-7.
The listed molecular formula is C24H30ClN3O5.
The listed molecular weight is 476.0 g/mol.
[6-(diethylaminomethyl)naphthalen-2-yl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate;hydrate;hydrochloride.
The source lists Givinostat and Givinostat hydrochloride monohydrate.